The role of the serum tube agglutination test in the monitoring of human brucellosis: evaluation of post-treatment SAT titers
Rev. Assoc. Med. Bras. (1992, Impr.)
;
68(9): 1234-1239, Sept. 2022. tab
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1406641
ABSTRACT
SUMMARY OBJECTIVE:
Positive results of the serum tube agglutination test that persist after treatment may be interpreted by clinicians as treatment failures. Therefore, our study examined the value of serum tube agglutination test in demonstrating treatment success.METHODS:
In this retrospective study conducted at a single center, the pre- and post-treatment serum tube agglutination test titers of patients diagnosed with brucellosis were compared.RESULTS:
The end-of-treatment serum tube agglutination test titer was negative in 24 (18%) of 139 patients diagnosed with brucellosis. The most common complaints of the patients were fever (78.4%), chills (88.5%), sweating (84.9%), anorexia (79.1%), and arthralgia (63.3%). The rate of positive blood culture before the treatment was 68.3%. The absence of fever (p=0.005) and arthralgia (p=0.024) and the pretreatment serum tube agglutination test titer of <1/160 (p=0.014) were significant markers of serological cure.CONCLUSION:
Although serum tube agglutination test is an effective and very successful test in the diagnosis of brucellosis, our study shows that serum tube agglutination test is not useful in demonstrating the treatment success of human brucellosis in the early post-treatment period.
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Observational study
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992, Impr.)
Journal subject:
EducaÆo em Sa£de
/
GestÆo do Conhecimento para a Pesquisa em Sa£de
/
Medicine
Year:
2022
Type:
Article
/
Project document
Affiliation country:
Turkey
Institution/Affiliation country:
Bitlis Tatvan State Hospital/TR
/
Haseki Training and Research Hospital/TR
Similar
MEDLINE
...
LILACS
LIS